Craig A. Barbarosh has served on our Board of Directors since November 2010. He has been a partner at the international law firm of Katten Muchin Rosenman LLP (“Katten”) since June 2012 where he serves on the Board of Directors and is a nationally recognized restructuring expert. From 1999 until joining Katten, Mr. Barbarosh was a partner at the law firm of Pillsbury Winthrop Shaw Pittman LLP where he served in several leadership positions including serving on the firm’s Board of Directors, as the Chair of the firm’s Board Strategy Committee as a co-leader of the firm’s national Insolvency & Restructuring practice section and as the Managing Partner of the firm’s Orange County office. Mr. Barbarosh also currently serves as a Director, Vice Chairman of the Board and Chair of the Compensation Committee of Nextgen Healthcare, Inc., a developer of healthcare information systems, and as a Director of Aratana Therapeutics, Inc., a specialty pharmaceutical company.
Mr. Barbarosh received a Juris Doctorate with honors from the University of the Pacific, McGeorge School of Law in 1992 and a Bachelor of Arts in Business Economics from the University of California at Santa Barbara in 1989. Mr. Barbarosh has received certificates from Harvard Business School for completing executive education courses on Effective Corporate Boards (2015), Strategic Financial Analysis for Business Evaluation (2010) and Private Equity and Venture Capital (2007).